Mackenzie Financial
NTUS

Mackenzie Financial’s Natus Medical Inc NTUS Stock Holding History

Mackenzie Financial’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,000
Closed -$298K – 678
2017
Q2 		$298K Buy
+8,000
New +$289K ﹤0.01% 558

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

Mackenzie Financial's NTUS Position: Q3 2017 in Review

Mackenzie Financial sold out of Natus Medical Inc (NTUS) in Q3 2017, closing a stake of 8,000 shares — an estimated $298K sold.

Mackenzie Financial first reported a position in NTUS in Q2 2017 and held it in 1 quarter. The position peaked at $298K in Q2 2017. 198 funds tracked by Wall St. Rank hold NTUS as of Q3 2017.

  • Mackenzie Financial reported no remaining Natus Medical Inc position as of Q3 2017 after selling out during the quarter.
  • Mackenzie Financial sold 8,000 Natus Medical Inc shares in Q3 2017, an estimated $298K.
  • Mackenzie Financial first reported a position in Natus Medical Inc in Q2 2017 and held it in 1 quarter.
  • Mackenzie Financial's Natus Medical Inc position peaked at $298K in Q2 2017.
  • 198 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2017.

Based on Mackenzie Financial's 13F filing for Q3 2017, filed 13 Nov 2017.